Cargando…

Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy

Heart failure (HF) is a common and serious comorbidity of diabetes. Oxidative stress has been associated with the pathogenesis of chronic diabetic complications including cardiomyopathy. The ability of antioxidants to inhibit injury has raised the possibility of new therapeutic treatment for diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guoguang, Li, Wei, Lu, Xiaohua, Zhao, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2011
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282438/ https://www.ncbi.nlm.nih.gov/pubmed/22355488 http://dx.doi.org/10.4081/hi.2011.e21

Ejemplares similares

Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats
por: Wang, Guo-guang, et al.
Publicado: (2013)

Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy
por: Liu, Limin, et al.
Publicado: (2020)

Residual alterations of cardiac and endothelial function in patients who recovered from Takotsubo cardiomyopathy
por: Zilberman, Liaz, et al.
Publicado: (2021)

Left ventricular‐only fusion pacing versus cardiac resynchronization therapy in heart failure patients: A randomized controlled trial
por: Su, Yangang, et al.
Publicado: (2021)

Titin‐truncating variants are associated with heart failure events in patients with left ventricular non‐compaction cardiomyopathy
por: Li, Shijie, et al.
Publicado: (2019)

Plasma free fatty acid is associated with ischemic cardiomyopathy and cardiac dysfunction severity in systolic heart failure patients with diabetes
por: Wei, Xue-Mei, et al.
Publicado: (2021)

Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus
por: Mills, Paul J., et al.
Publicado: (2019)

A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus
por: Williams, Brent A., et al.
Publicado: (2019)

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline
por: Julián, María Teresa, et al.
Publicado: (2020)

GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
por: Shiraki, Aya, et al.
Publicado: (2019)

Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020)

Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review
por: Chery, Godefroy, et al.
Publicado: (2020)

Prognostic value of elevated cardiac troponin I in patients with intracerebral hemorrhage
por: He, Yangchun, et al.
Publicado: (2019)

Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy
por: Cooney, Ryan, et al.
Publicado: (2022)

Early noncardiovascular organ failure and mortality in the cardiac intensive care unit
por: Jentzer, Jacob C., et al.
Publicado: (2020)

Electrocardiographic findings in peripartum cardiomyopathy
por: Honigberg, Michael C., et al.
Publicado: (2019)

Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population‐based cohort study
por: Lee, Sharen, et al.
Publicado: (2021)

Prevention of sudden cardiac death in hypertrophic cardiomyopathy: Risk assessment using left atrial diameter predicted from left atrial volume
por: Mills, Helen, et al.
Publicado: (2020)

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012)

Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy
por: Li, Peijin, et al.
Publicado: (2021)

Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Cardiac troponin I predicts clinical outcome of patients with cancer at emergency department
por: Park, Soo Hyun, et al.
Publicado: (2020)

Association between serum cystatin C and early impairment of cardiac function and structure in type 2 diabetes patients with normal renal function
por: Huang, Zhuoshan, et al.
Publicado: (2022)

Outcomes and predictors of patients with moderate or severe functional mitral regurgitation and nonischemic dilated cardiomyopathy
por: Li, Jiangtao, et al.
Publicado: (2023)

Handgrip strength and the prognosis of patients with heart failure: A meta‐analysis
por: Wang, Yu, et al.
Publicado: (2023)

Ventricular conduction abnormality in patients with mild to moderate cardiomyopathy
por: Dhande, Mehak, et al.
Publicado: (2023)

Are there differences in acute phase inflammation markers regarding the type of heart failure?
por: Sánchez-Lázaro, Ignacio J., et al.
Publicado: (2011)

Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism
por: Ojaimi, Caroline, et al.
Publicado: (2010)

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine
por: Chen, Weena J. Y., et al.
Publicado: (2017)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes
por: WANG, YONG-BIN, et al.
Publicado: (2015)

HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy
por: Jin, B., et al.
Publicado: (2016)

Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2017)

Endothelial MICU1 alleviates diabetic cardiomyopathy by attenuating nitrative stress-mediated cardiac microvascular injury
por: Shi, Xide, et al.
Publicado: (2023)

Left ventricular strain and untwist in hypertrophic cardiomyopathy: Relation to exercise capacity
por: Abozguia, Khalid, et al.
Publicado: (2010)

Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methods
por: Wang, Liming, et al.
Publicado: (2016)

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping
por: Rutherford, Elaine, et al.
Publicado: (2016)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

Cytokine profile and lymphocyte subsets in type 2 diabetes
por: Francisco, C.O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mgd488oftqm8k9q5rn1sc0ja7t